The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Ocular indicators of Alzheimer’s: exploring disease in the retina
Open accessAbstract
Although historically perceived as a disorder confined to the brain, our understanding of Alzheimer’s disease (AD) has expanded to include extra-cerebral manifestation, with mounting evidence of abnormalities in the eye. Among ocular tissues, the retina, a developmental outgrowth of the brain, is marked by an array of pathologies in patients suffering from AD, including nerve fiber layer thinning, degeneration of retinal ganglion cells, and changes to vascular parameters. While the hallmark pathological signs of AD, amyloid β-protein (Aβ) plaques and neurofibrillary tangles (NFT) comprising hyperphosphorylated tau (pTau) protein, have long been described in the brain, identification of these characteristic biomarkers in the retina has only recently been reported. In particular, Aβ deposits were discovered in post-mortem retinas of advanced and early stage cases of AD, in stark contrast to non-AD controls. Subsequent studies have reported elevated Aβ42/40 peptides, morphologically diverse Aβ plaques, and pTau in the retina. In line with the above findings, animal model studies have reported retinal Aβ deposits and tauopathy, often correlated with local inflammation, retinal ganglion cell degeneration, and functional deficits. This review highlights the converging evidence that AD manifests in the eye, especially in the retina, which can be imaged directly and non-invasively. Visual dysfunction in AD patients, traditionally attributed to well-documented cerebral pathology, can now be reexamined as a direct outcome of retinal abnormalities. As we continue to study the disease in the brain, the emerging field of ocular AD warrants further investigation of how the retina may faithfully reflect the neurological disease. Indeed, detection of retinal AD pathology, particularly the early presenting amyloid biomarkers, using advanced high-resolution imaging techniques may allow large-scale screening and monitoring of at-risk populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,098
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Neuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660
The retina as a window to the brain—from eye research to CNS disorders
London, A., Benhar, I., & Schwartz, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.227 · Cited by 1,403
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Goedert, M. (2015) · Science · doi:10.1126/science.1255555 · Cited by 976
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256697.20968.d7 · Cited by 748
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009) · Nature · doi:10.1038/nature08538 · Cited by 702
Optic-Nerve Degeneration in Alzheimer's Disease
Hinton, D. R., Sadun, A. A., Blanks, J. C., & Miller, C. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608213150804 · Cited by 694
Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., Schwartz, M., & Farkas, D. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.020 · Cited by 672
Self-citationA genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Wiseman, F. K., Al-Janabi, T., Hardy, J., Karmiloff-Smith, A., Nizetic, D., Tybulewicz, V. L. J., Fisher, E. M. C., & Strydom, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3983 · Cited by 562
Retinal Abnormalities in Early Alzheimer’s Disease
Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W., & Schepens, C. L. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1029 · Cited by 504
Inflammatory process in Alzheimer's Disease
Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427
The retina in Parkinson's disease
Archibald, N. K., Clarke, M. P., Mosimann, U. P., & Burn, D. J. (2009) · Brain · doi:10.1093/brain/awp068 · Cited by 408
Iseri, P. K., Altinaş, Ö., Tokay, T., & Yüksel, N. (2006) · Journal of Neuro-Ophthalmology · doi:10.1097/01.wno.0000204645.56873.26 · Cited by 400
Melanopsin retinal ganglion cell loss in Alzheimer disease
La Morgia, C., Ross‐Cisneros, F. N., Koronyo, Y., Hannibal, J., Gallassi, R., Cantalupo, G., Sambati, L., Pan, B. X., Tozer, K. R., Barboni, P., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24548 · Cited by 390
Self-citationGoldstein, L. E., Muffat, J. A., Cherny, R. A., Moir, R. D., Ericsson, M. H., Huang, X., Mavros, C., Coccia, J. A., Faget, K. Y., Fitch, K. A., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12981-9 · Cited by 363
Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
Paquet, C., Boissonnot, M., Roger, F., Dighiero, P., Gil, R., & Hugon, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.090 · Cited by 353
Optic Nerve Damage in Alzheimer's Disease
Sadun, A. A., & Bassi, C. J. (1990) · Ophthalmology · doi:10.1016/s0161-6420(90)32621-0 · Cited by 346
Morphological and functional retinal impairment in Alzheimer's disease patients
Parisi, V., Restuccia, R., Fattapposta, F., Mina, C., Bucci, M. G., & Pierelli, F. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00620-4 · Cited by 344
Recent developments in optical coherence tomography for imaging the retina
van Velthoven, M. E. J., Faber, D. J., Verbraak, F. D., van Leeuwen, T. G., & de Smet, M. D. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.10.002 · Cited by 343
Targeting amyloid-β in glaucoma treatment
Guo, L., Salt, T. E., Luong, V., Wood, N., Cheung, W., Maass, A., Ferrari, G., Russo-Marie, F., Sillito, A. M., Cheetham, M. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703707104 · Cited by 342
Complex visual disturbances in Alzheimer's disease
Mendez, M. F., Mendez, M. A., Martin, R., Smyth, K. A., & Whitehouse, P. J. (1990) · Neurology · doi:10.1212/wnl.40.3_part_1.439 · Cited by 335
Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina
Blanks, J. C., Torigoe, Y., Hinton, D. R., & Blanks, R. H. I. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00010-3 · Cited by 330
Microvascular network alterations in the retina of patients with Alzheimer's disease
Cheung, C. Y., Ong, Y. T., Ikram, M. K., Ong, S. Y., Li, X., Hilal, S., Catindig, J. S., Venketasubramanian, N., Yap, P., Seow, D., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.06.009 · Cited by 315
Vision and cognition in Alzheimer’s disease
Rizzo, M. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(00)00023-3 · Cited by 308
Retinal ganglion cells in Alzheimer's disease and aging
Curcio, C. A., & Drucker, D. N. (1993) · Annals of Neurology · doi:10.1002/ana.410330305 · Cited by 308
Amyloid-β Deposits Lead to Retinal Degeneration in a Mouse Model of Alzheimer Disease
Ning, A., Cui, J., To, E., Ashe, K. H., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1849 · Cited by 303
Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease
Kesler, A., Vakhapova, V., Korczyn, A. D., Naftaliev, E., & Neudorfer, M. (2011) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.02.014 · Cited by 298
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
Frost, S., Kanagasingam, Y., Sohrabi, H., Vignarajan, J., Bourgeat, P., Salvado, O., Villemagne, V, Rowe, C. C., Lance Macaulay, S., Szoeke, C., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.150 · Cited by 297
Retinal ganglion cell degeneration in Alzheimer's disease
Blanks, J. C., Hinton, D. R., Sadun, A. A., & Miller, C. A. (1989) · Brain Research · doi:10.1016/0006-8993(89)90653-7 · Cited by 297
Hof, P. R., & Morrison, J. H. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.903010106 · Cited by 294
Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL
Blanks, J. C., Schmidt, S. Y., Torigoe, Y., Porrello, K. V., Hinton, D. R., & Blanks, R. H. I. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00009-7 · Cited by 287
A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster
Finelli, A., Kelkar, A., Song, H.-J., Yang, H., & Konsolaki, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.001 · Cited by 287
Age-Dependent Neurodegeneration and Alzheimer-Amyloid Plaque Formation in Transgenic Drosophila
Greeve, I., Kretzschmar, D., Tschäpe, J.-A., Beyn, A., Brellinger, C., Schweizer, M., Nitsch, R. M., & Reifegerste, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0283-04.2004 · Cited by 287
High Occurrence Rate of Glaucoma among Patients with Alzheimer’s Disease
Bayer, A. U., Ferrari, F., & Erb, C. (2002) · European Neurology · doi:10.1159/000047976 · Cited by 286
Glaucoma: the retina and beyond
Davis, B. M., Crawley, L., Pahlitzsch, M., Javaid, F., & Cordeiro, M. F. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1609-2 · Cited by 281
Parallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280
Ng, S., Villemagne, V. L., Berlangieri, S., Lee, S.-T., Cherk, M., Gong, S. J., Ackermann, U., Saunder, T., Tochon-Danguy, H., Jones, G., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037762 · Cited by 258
Local Neuroinflammation and the Progression of Alzheimer's Disease
McGeer, P. L., & McGeer, E. G. (2002) · Journal of Neurovirology · doi:10.1080/13550280290100969 · Cited by 255
Dentchev, T., Milam, A. H., Lee, V. M. ‐., Trojanowski, J. Q., & Dunaief, J. L. (2003) · PubMed · Cited by 252
Lu, Y., Li, Z., Zhang, X., Ming, B., Jia, J., Wang, R., & Ma, D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.006 · Cited by 248
Brain and Retinal Pericytes: Origin, Function and Role
Trost, A., Lange, S., Schroedl, F., Bruckner, D., Motloch, K. A., Bogner, B., Kaser-Eichberger, A., Strohmaier, C., Runge, C., Aigner, L., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00020 · Cited by 244
Optic Disc and Optic Cup Segmentation Methodologies for Glaucoma Image Detection: A Survey
Almazroa, A., Burman, R., Raahemifar, K., & Lakshminarayanan, V. (2015) · Journal of Ophthalmology · doi:10.1155/2015/180972 · Cited by 234
High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease
Tamura, H., Kawakami, H., Kanamoto, T., Kato, T., Yokoyama, T., Sasaki, K., Izumi, Y., Matsumoto, M., & Mishima, H. K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.02.009 · Cited by 232
Perez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J., & Xu, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2384 · Cited by 230
Glaucoma ocular Alzheimer s disease
McKinnon, S. J. (2003) · Frontiers in Bioscience · doi:10.2741/1172 · Cited by 228
Assessment of Visual Impairment in Patients With Alzheimer's Disease
Sadun, A. A., Borchert, M., DeVita, E., Hinton, D. R., & Bassi, C. J. (1987) · American Journal of Ophthalmology · doi:10.1016/0002-9394(87)90001-8 · Cited by 225
The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer's Brain and Retinal Disease
Sivak, J. M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10827 · Cited by 220
Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease
Kirbas, S., Turkyilmaz, K., Anlar, O., Tufekci, A., & Durmus, M. (2013) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318267fd5f · Cited by 217
Marziani, E., Pomati, S., Ramolfo, P., Cigada, M., Giani, A., Mariani, C., & Staurenghi, G. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12046 · Cited by 215
Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis
Coppola, G., Di Renzo, A., Ziccardi, L., Martelli, F., Fadda, A., Manni, G., Barboni, P., Pierelli, F., Sadun, A. A., & Parisi, V. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134750 · Cited by 205
Luibl, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25843 · Cited by 203 · cited 19×
“Among these, parameters of amyloid aggregation coupled with RGC degeneration in the superior quadrant of the innermost retinal layers (i.e., NFL and GCL) might distinguish ocular pathology specific to AD from that observed in other neurodegenerative diseases, such as AMD and glaucoma [92, 93, 116, 120].”
BackgroundInfluentialPrion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target
Holmes, B. B., & Diamond, M. I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.549295 · Cited by 202
Katz, B., Rimmer, S., Iragui, V., & Katzman, R. (1989) · Annals of Neurology · doi:10.1002/ana.410260207 · Cited by 198
Koronyo, Y., Salumbides, B. C., Black, K. L., & Koronyo-Hamaoui, M. (2012) · Neurodegenerative Diseases · doi:10.1159/000335154 · Cited by 196
Self-citationSaccadic eye movement dysfunction in Alzheimer's disease
Fletcher, W. A., & Sharpe, J. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200405 · Cited by 196
Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
AV45-A11 Study Group, Doraiswamy, P. M., Sperling, R. A., Johnson, K., Reiman, E. M., Wong, T. Z., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.9 · Cited by 195 · cited 1×
“, (11)C-Pittsburgh compound B, PiB [125], (18)F-florbetapir [45], (18)F-flutemetamol [80], (18)F-florbetaben [173], (18)F-TKH5105, and (18)F-T807 [89]) provides disease specificity and facilitates ongoing research.”
Ascaso, F. J., Cruz, N., Modrego, P. J., Lopez-Anton, R., Santabárbara, J., Pascual, L. F., Lobo, A., & Cristóbal, J. A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7374-z · Cited by 195
α‐synuclein in the inner retina in parkinson disease
Bodis‐Wollner, I., Kozlowski, P. B., Glazman, S., & Miri, S. (2014) · Annals of Neurology · doi:10.1002/ana.24182 · Cited by 192
Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice
Schön, C., Hoffmann, N. A., Ochs, S. M., Burgold, S., Filser, S., Steinbach, S., Seeliger, M. W., Arzberger, T., Goedert, M., Kretzschmar, H. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053547 · Cited by 192
Ding, J.-D., Johnson, L. V., Herrmann, R., Farsiu, S., Smith, S. G., Groelle, M., Mace, B. E., Sullivan, P., Jamison, J. A., Kelly, U., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100901108 · Cited by 188
Liu, B., Rasool, S., Yang, Z., Glabe, C. G., Schreiber, S. S., Ge, J., & Tan, Z. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090159 · Cited by 182 · cited 8×
“Evidence of pTau has been observed from the GCL to the ONL in the Tg2576 mouse and in the soma of RGCs in the APPSWE/PS1ΔE9 mouse (Table 2) [117, 187].”
BackgroundResultInfluentialMoreno-Ramos, T., Benito-León, J., Villarejo, A., & Bermejo-Pareja, F. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121975 · Cited by 181
Ophthalmologic manifestations of Alzheimer's disease
Katz, B., & Rimmer, S. (1989) · Survey of Ophthalmology · doi:10.1016/0039-6257(89)90127-6 · Cited by 181
Javaid, F. Z., Brenton, J., Guo, L., & Cordeiro, M. F. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00055 · Cited by 178
Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
Mathis, C. A., Mason, N. S., Lopresti, B. J., & Klunk, W. E. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.07.001 · Cited by 175
Gharbiya, M., Trebbastoni, A., Parisi, F., Manganiello, S., Cruciani, F., D'Antonio, F., De Vico, U., Imbriano, L., Campanelli, A., & De Lena, C. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-132039 · Cited by 174
Dementia of the eye: the role of amyloid beta in retinal degeneration
Ratnayaka, J. A., Serpell, L. C., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.100 · Cited by 172
Retinal blood flow in mild cognitive impairment and Alzheimer's disease
Feke, G. T., Hyman, B. T., Stern, R. A., & Pasquale, L. R. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.01.004 · Cited by 172
Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina.
Löffler, K. U., Edward, D. P., & Tso, M. O. M. (1995) · PubMed · Cited by 169
Retinal microvascular network attenuation in Alzheimer's disease
Williams, M. A., McGowan, A., Cardwell, C. R., Cheung, C. Y.-L., Craig, D., Passmore, P., Silvestri, G., Maxwell, A. P., & McKay, G. J. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.04.001 · Cited by 169
Visual field loss in senile dementia of the Alzheimer's type
Trick, G. L., Trick, L. R., Morris, P., & Wolf, M. (1995) · Neurology · doi:10.1212/wnl.45.1.68 · Cited by 166
Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging
Danesh-Meyer, H. V., Birch, H., Ku, J. Y.-F., Carroll, S., & Gamble, G. (2006) · Neurology · doi:10.1212/01.wnl.0000244490.07925.8b · Cited by 164
Optic nerve head and nerve fiber layer in Alzheimer's disease
Tsai, C. S. (1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080020045040 · Cited by 163
Gao, L., Liu, Y., Li, X., Bai, Q., & Liu, P. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.10.011 · Cited by 163
Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease
Fox, N. C., Warrington, E. K., & Rossor, M. N. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00496-1 · Cited by 162
Ardiles, Á. O., Tapia‐Rojas, C., Mandal, M., Alexandre, F., Kirkwood, A., Inestrosa, N. C., & Palacios, A. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201209109 · Cited by 161
Ho, C., Troncoso, J. C., Knox, D., Stark, W., & Eberhart, C. G. (2014) · Brain Pathology · doi:10.1111/bpa.12070 · Cited by 159
Liu, D., Zhang, L., Li, Z., Zhang, X., Wu, Y., Yang, H., Min, B., Zhang, X., Ma, D., & Lu, Y. (2015) · BMC Neurology · doi:10.1186/s12883-015-0268-6 · Cited by 158
Risacher, S. L., WuDunn, D., Pepin, S. M., MaGee, T. R., McDonald, B. C., Flashman, L. A., Wishart, H. A., Pixley, H. S., Rabin, L. A., Paré, N., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.007 · Cited by 158
Alzheimers Disease and Retinal Neurodegeneration
Guo, L., Duggan, J., & Cordeiro, M. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274491 · Cited by 158
Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome
Moncaster, J. A., Pineda, R., Moir, R. D., Lu, S., Burton, M. A., Ghosh, J. G., Ericsson, M., Soscia, S. J., Mocofanescu, A., Folkerth, R. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010659 · Cited by 157
Microvascular Structure and Network in the Retina of Patients With Ischemic Stroke
Ong, Y., Silva, D. A. D., Cheung, C. Y.-L., Chang, H., Chen, C., Wong, M. C., Wong, T. Y., & Ikram, M. K. (2013) · Stroke · doi:10.1161/strokeaha.113.001741 · Cited by 157
Abnormal pattern electroretinograms in patients with senile dementia of the alzheimer type
Trick, G. L., Barris, M. C., & Bickler‐Bluth, M. (1989) · Annals of Neurology · doi:10.1002/ana.410260208 · Cited by 155
Ocular changes in TgF344-AD rat model of Alzheimer's disease
Tsai, Y., Lu, B., Ljubimov, A. V., Girman, S., Ross-Cisneros, F. N., Sadun, A. A., Svendsen, C. N., Cohen, R. M., & Wang, S. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12888 · Cited by 153
Parisi, V. (2003) · Seminars in Ophthalmology · doi:10.1076/soph.18.2.50.15855 · Cited by 147
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146
Bayhan, H. A., Bayhan, S. A., Çelikbilek, A., Tanık, N., & Gürdal, C. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12386 · Cited by 146
Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease
Dutescu, R. M., Li, Q., Crowston, J. G., Masters, C. L., Baird, P. N., & Culvenor, J. G. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1060-3 · Cited by 145
Trajectories of brain loss in aging and the development of cognitive impairment
Carlson, N. E., Moore, M. M., Dame, A., Howieson, D., Silbert, L. C., Quinn, J. F., & Kaye, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000280577.43413.d9 · Cited by 144
Neurotoxic effects induced by the Drosophila amyloid-β peptide suggest a conserved toxic function
Carmine-Simmen, K., Proctor, T., Tschäpe, J. A., Poeck, B., Triphan, T., Strauß, R., & Kretzschmar, D. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.014 · Cited by 144
Motion Perception and Alzheimer's Disease
Gilmore, G. C., Wenk, H. E., Naylor, L. A., & Koss, E. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.p52 · Cited by 142
Optical coherence tomography of the retina: applications in neurology
Jindahra, P., Hedges, T. R., Mendoza‐Santiesteban, C. E., & Plant, G. T. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328334e99b · Cited by 133
Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity
Wegmann, S., Maury, E. A., Kirk, M. J., Saqran, L., Roe, A., DeVos, S. L., Nicholls, S., Fan, Z., Takeda, S., Cagsal‐Getkin, O., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201592748 · Cited by 132
More, S. S., & Vince, R. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500242z · Cited by 131
Structural and Functional Impairment of the Retina and Optic Nerve in Alzheimer’s Disease
Moschos, M. M., Markopoulos, I., Chatziralli, I., ROUVAS, A. A., Papageorgiou, S. G., Ladas, I., & Vassilopoulos, D. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455340 · Cited by 130
Amyloid‐β(1‐42) alters structure and function of retinal pigmented epithelial cells
Bruban, J., Glotin, A., Dinet, V., Chalour, N., Sennlaub, F., Jonet, L., An, N., Faussat, A. M., & Mascarelli, F. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00456.x · Cited by 129
Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease
Alexandrov, P. N., Pogue, A., Bhattacharjee, S., & Lukiw, W. J. (2011) · Neuroreport · doi:10.1097/wnr.0b013e3283497334 · Cited by 128
Krasodomska, K., Lubiński, W., Potemkowski, A., & Honczarenko, K. (2010) · Documenta Ophthalmologica · doi:10.1007/s10633-010-9238-x · Cited by 127
Gupta, V., Chitranshi, N., Gupta, V. B., Golzan, M., Dheer, Y., Wall, R. V., Georgevsky, D., King, A. E., Vickers, J. C., Chung, R. S., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.059 · Cited by 127
Human-like rodent amyloid-β-peptide determines Alzheimer pathology in aged wild-type Octodon degu
Inestrosa, N. C., Reyes, A. E., Chacón, M. A., Cerpa, W. F., Villalón, A., Montiel, J. F., Merabachvili, G., Aldunate, R., Bozinovic, F., & Aboitiz, F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.016 · Cited by 124
Ocular Biomarkers for Early Detection of Alzheimer's Disease
Frost, S. M., Martins, R. N., & Kanagasingam, Y. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100819 · Cited by 117
The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness
Öktem, E. Ö., Derle, E., Kibaroğlu, S., Öktem, Ç., Akkoyun, İ., & Can, U. A. (2015) · Neurological Sciences · doi:10.1007/s10072-014-2055-3 · Cited by 116
Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo
Cordeiro, M. F., Guo, L., Coxon, K. M., Duggan, J., Nizari, S., Normando, E. M., Sensi, S. L., Sillito, A. M., Fitzke, F. W., Salt, T. E., et al. (2010) · Cell Death and Disease · doi:10.1038/cddis.2009.3 · Cited by 115
Retinal Remodeling and Metabolic Alterations in Human AMD
Jones, B. W., Pfeiffer, R. L., Ferrell, W. D., Watt, C. B., Tucker, J., & Marc, R. E. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00103 · Cited by 115
Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease
Williams, P. A., Thirgood, R. A., Oliphant, H., Frizzati, A., Littlewood, E., Votruba, M., Good, M. A., Williams, J. H., & Morgan, J. E. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.006 · Cited by 112
Nolan, J. M., Loskutova, E., Howard, A. N., Moran, R., Mulcahy, R., Stack, J., Bolger, M., Dennison, J. L., Akuffo, K. O., Owens, N., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140507 · Cited by 111
No Increased Risk of Developing Alzheimer Disease in Patients With Glaucoma
Kessing, L. V., Lopez, A. G., Andersen, P. K., & Kessing, S. V. (2007) · Journal of Glaucoma · doi:10.1097/ijg.0b013e31802b3527 · Cited by 110
Detection of Retinal Nerve Fiber Layer Defects in Alzheimer’s Disease Using SD-OCT
Kromer, R., Serbecic, N., Hausner, L., Froelich, L., Aboul‐Enein, F., & Beutelspacher, S. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00022 · Cited by 110
PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
James, O. G., Doraiswamy, P. M., & Borges‐Neto, S. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00038 · Cited by 107
Chang, L. Y. L., Lowe, J., Ardiles, A., Lim, J., Grey, A. C., Robertson, K., Danesh‐Meyer, H., Palacios, A. G., & Acosta, M. L. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.06.004 · Cited by 106
Morin, P. J., Abraham, C. R., Amaratunga, A., Johnson, R. J., Huber, G., Sandell, J. H., & Fine, R. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb02147.x · Cited by 105
Tiepolt, S., Hesse, S., Patt, M., Luthardt, J., Schroeter, M. L., Hoffmann, K., Weise, D., Gertz, H., Sabri, O., & Barthel, H. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3353-1 · Cited by 97
Jentsch, S., Schweitzer, D., Schmidtke, K., Peters, S., Dawczynski, J., Bär, K., & Hammer, M. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12609 · Cited by 96
Vision function abnormalities in Alzheimer disease
Tzekov, R., & Mullan, M. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2013.10.002 · Cited by 94
Surguchov, A. P., McMahan, B., Masliah, E., & Surgucheva, I. G. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1129 · Cited by 92
Retinal nerve fiber layer abnormalities in Alzheimer's disease
Hedges, T. R., Galves, R. P., Speigelman, D., Barbas, N. R., Peli, E., & Yardley, C. J. (1996) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1996.tb00090.x · Cited by 92
Larrosa, J. M., García‐Martín, E., BAMBO, M., Pinilla, J., Polo, V., Otín, S., Satué, M., Herrero, R., & Pablo, L. E. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13629 · Cited by 91
The disengagement of visual attention in Alzheimer's disease: a longitudinal eye-tracking study
Crawford, T. J., Devereaux, A., Higham, S., & Kelly, C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00118 · Cited by 90
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
Steardo, L., Bronzuoli, M. R., Iacomino, A., Esposito, G., Steardo, L., & Scuderi, C. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00259 · Cited by 90
Alternative pathways for production of β-amyloid peptides of Alzheimer's disease
HOOK, V. Y. H., Schechter, I., Demuth, H., & Hook, G. (2008) · Biological Chemistry · doi:10.1515/bc.2008.124 · Cited by 90
Granholm, E. L., Morris, S., Galasko, D. R., Shults, C. W., Rogers, E., & Vukov, B. (2003) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(02)00122-8 · Cited by 89
Melanopsin-expressing retinal ganglion cells: implications for human diseases
La Morgia, C., Ross-Cisneros, F. N., Hannibal, J., Montagna, P., Sadun, A. A., & Carelli, V. (2011) · Vision Research · doi:10.1016/j.visres.2010.07.023 · Cited by 84
Distinct visual motion processing impairments in aging and Alzheimer’s disease
Kavcic, V., Vaughn, W. J., & Duffy, C. J. (2010) · Vision Research · doi:10.1016/j.visres.2010.12.004 · Cited by 84
Hasegawa, M. (2016) · Biomolecules · doi:10.3390/biom6020024 · Cited by 82
Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice
Park, S. W., Kim, J. H., Mook‐Jung, I., Kim, K.-W., Park, W. J., Park, K. H., & Kim, J. H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.008 · Cited by 78
Oculo‐visual changes and clinical considerations affecting older patients with dementia
Armstrong, R. A., & Kergoat, H. (2015) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12220 · Cited by 77
Anti-Aggregating Effect of the Naturally Occurring Dipeptide Carnosine on Aβ1-42 Fibril Formation
Aloisi, A., Barca, A., Romano, A., Guerrieri, S., Storelli, C., Rinaldi, R., & Verri, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068159 · Cited by 77
Greater Attenuation of Retinal Nerve Fiber Layer Thickness in Alzheimer's Disease Patients
Shi, Z., Wu, Y., Wang, M., Cao, J., Feng, W. G., Cheng, Y., Li, C., & Shen, Y. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131898 · Cited by 74
Vertebrate retina and hypothalamus development
Byerly, M. S., & Blackshaw, S. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.22 · Cited by 74
Cutler, T., Sarkar, A., Moran, M. T., Steffensmeier, A. M., Puli, O. R., Mancini, G., Tare, M., Gogia, N., & Singh, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137691 · Cited by 72
Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease
Edwards, M. M., Rodriguez, J. J., Gutiérrez-Lanza, R., Yates, J., Verkhratsky, A., & Lutty, G. A. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.08.006 · Cited by 72
Kergoat, H., Kergoat, M., Justino, L., Chertkow, H. M., Robillard, A., & Bergman, H. (2001) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2001.079002187.x · Cited by 71
Cao, L., Wang, H., Wang, F., Xu, D., Liu, F., & Liu, C. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11612 · Cited by 70
Clavaguera, F., Grueninger, F., & Tolnay, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.037 · Cited by 70
Heurling, K., Leuzy, A., Zimmer, E. R., Lubberink, M., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3208-1 · Cited by 66
Brain metabolism and Alzheimer's disease: The prospect of a metabolite-based therapy
Thomas, S. C., Alhasawi, A. A., Appanna, V. D., Auger, C., & Appanna, V. D. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0511-7 · Cited by 56
Ocular manifestations of Alzheimer's disease in animal models
Parnell, M., Guo, L., Abdi, M., & Cordeiro, M. F. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/786494 · Cited by 56 · cited 1×
“The latter, predominantly involving transgenic (Tg) rodents, reported similar retinal patterns, where Aβ deposits often colocalize with sites of apoptosis, neuroinflammation, impairments of function and structure, and plaque formation that even precedes that seen in the brain [46, 107, 108, 139, 148, 149, 152].”
BackgroundPrice, D. L., Rockenstein, E. M., Mante, M., Adame, A., Overk, C., Spencer, B. J., Duong‐Polk, K., Bonhaus, D. W., Lindsey, J. D., & Masliah, E. (2016) · Scientific Reports · doi:10.1038/srep29523 · Cited by 56
Peripheral Immune Signatures in Alzheimer Disease
Goldeck, D., Witkowski, J. M., Fülöp, T., & Pawelec, G. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160222112444 · Cited by 55
Gao, L., Chen, X., Tang, Y., Zhao, J., Li, Q., Fan, X., Xu, H., & Yin, Z. Q. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.04.013 · Cited by 54
SPECT Imaging Agents for Detecting Cerebral β-Amyloid Plaques
Ono, M., & Saji, H. (2011) · International Journal of Molecular Imaging · doi:10.1155/2011/543267 · Cited by 54
Kerbage, C., Sadowsky, C., Tariot, P. N., Agronin, M., Alva, G., Turner, F. D., Nilan, D., Cameron, A., Cagle, G. D., & Hartung, P. D. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513520214 · Cited by 54
Alzheimer’s Disease-Related Protein Expression in the Retina of Octodon degus
Du, L. Y., Chang, L., Ardiles, Á. O., Tapia‐Rojas, C., Araya, J., Inestrosa, N. C., Palacios, A. G., & Acosta, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135499 · Cited by 53
Zhao, H., Chang, R., Che, H., Wang, J., Yang, L., Wei, F., Xia, Y., Li, N., Ma, Q., & Wang, X. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.026 · Cited by 53
Normal tension glaucoma and Alzheimer disease: comorbidity?
Bach‐Holm, D., Kessing, S. V., Mogensen, U. B., Forman, J. L., Andersen, P. K., & Kessing, L. V. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02125.x · Cited by 53
Kerbage, C., Sadowsky, C., Jennings, D. L., Cagle, G. D., & Hartung, P. D. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00062 · Cited by 53
Analysis of optic disk color changes in Alzheimer's disease: A potential new biomarker
BAMBO, M., García‐Martín, E., Gutierrez-Ruiz, F., Pinilla, J., Oliván, S. P., Larrosa, J. M., Polo, V., & Pablo, L. E. (2015) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2015.02.016 · Cited by 49
Drusen maculopathy: a risk factor for visual deterioration
Algvere, P. V., Kvanta, A., & Seregard, S. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13011 · Cited by 49
Alzheimer's Disease and the Early Signs of Age-Related Macular Degeneration
Frost, S. M., Guymer, R. H., Aung, K. Z., Macaulay, S. L., Sohrabi, H. R., Bourgeat, P., Salvado, O., Rowe, C. C., Ames, D. J., Masters, C. L., et al. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160603003800 · Cited by 46
Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin
Parthasarathy, R., Chow, K. M., Derafshi, Z., Fautsch, M. P., Hetling, J. R., Rodgers, D. W., Hersh, L. B., & Pepperberg, D. R. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.027 · Cited by 45
Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice
Pogue, A. I., Dua, P., Hill, J. M., & Lukiw, W. J. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.07.009 · Cited by 41
Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease
Michael, R., Rosandić, J., Montenegro, G. A., Lobato, E., Tresserra, F., Barraquer, R. I., & Vrensen, G. F. J. M. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.10.012 · Cited by 41
Stimulus Contrast and Word Reading Speed in Alzheimer's Disease
Gilmore, G. C., Groth, K. E., & Thomas, C. W. (2005) · Experimental Aging Research · doi:10.1080/03610730590882828 · Cited by 38
Presenilin expression in the ocular lens
Frederikse, P. H., & Zigler, J. S. (1998) · Current Eye Research · doi:10.1076/ceyr.17.9.947.5135 · Cited by 38
Ávila, J., Pallas‐Bazarra, N., Bolós, M., Sayas, C. L., & Hernández, F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1131269 · Cited by 38
Tsuruma, K., Tanaka, Y., Shimazawa, M., & Hara, H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06724.x · Cited by 35
Frederikse, P. H., & Ren, X. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64475-6 · Cited by 35
Retinal examination for the diagnosis of Alzheimer's disease
Kayabasi, U. (2014) · International Journal of Ophthalmic & Pathology · doi:10.4172/2324-8599.1000145 · Cited by 34
Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer’s Disease
Salobrar‐García, E., de Hoz, R., Rojas, B., Ramirez, A. I., Salazar, J. J., Yubero, R., Gil, P., Triviño, A., & Ramirez, J. M. (2015) · Journal of Ophthalmology · doi:10.1155/2015/736949 · Cited by 32
ApoE4 Induces Synaptic and ERG Impairments in the Retina of Young Targeted Replacement ApoE4 Mice
Antes, R., Ezra-Elia, R., Weinberger, D., Solomon, A., Ofri, R., & Michaelson, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064949 · Cited by 32
Yang, Y. J., Shiao, C., Hemingway, J. F., Jorstad, N. L., Shalloway, B. R., Chang, R. C., & Keene, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064246 · Cited by 31
Lee, S. H., Lee, E. J., & Kim, T. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.2453 · Cited by 30
Protective effects of a dimeric derivative of ferulic acid in animal models of Alzheimer's disease
Jung, J., Yan, J.-J., Li, H.-M., Sultan, M. T., Yu, J., Lee, H.-S., Shin, K.-J., & Song, D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.047 · Cited by 30
Kurna, S. A., Akar, G., Altun, A., Agirman, Y., Gözke, E., & Şengör, T. (2014) · International Ophthalmology · doi:10.1007/s10792-014-0004-z · Cited by 29
Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology
Calabresi, P. A., Balcer, L. J., & Frohman, E. M. (2010) · Brain · doi:10.1093/brain/awq133 · Cited by 29
Cell type-specific processing of human Tau proteins in Drosophila
Grammenoudi, S., Kosmidis, S., & Skoulakis, E. M. C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.045 · Cited by 29
Lee, C., Ko, D., Suh, Y.-W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123229 · Cited by 28
A test of lens opacity as an indicator of preclinical Alzheimer Disease
Bei, L., Shui, Y., Bai, F., Nelson, S. K., Stavern, G. P. V., & Beebe, D. C. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.03.010 · Cited by 25
He, Y., Zhao, H., & Su, G. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0173-7 · Cited by 23
Presence and Release of ATP from the Retina in an Alzheimer's Disease Model
de Lara, M. J. P., & Pintor, J. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141005 · Cited by 19
Fraller, D. B. (2013) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3182829024 · Cited by 15
Schwartz, M., Bukshpan, S., & Kunis, G. (2008) · BioDrugs · doi:10.2165/00063030-200822050-00002 · Cited by 14
The effects of the apoE4 genotype on the developing mouse retina
Maharshak, I., Salomon‐Zimri, S., Antes, R., Liraz, O., Nisgav, Y., Livnat, T., Weinberger, D., Colton, C. A., Solomon, A., & Michaelson, D. M. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.11.001 · Cited by 9
Cited by
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease
Koronyo, Y., Biggs, D., Barron, E., Boyer, D. S., Pearlman, J. A., Au, W. J., Kile, S. J., Blanco, A., Fuchs, D.-T., Ashfaq, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93621 · Cited by 510
Self-citationThe role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
Spectral-Domain OCT Measurements in Alzheimer’s Disease
Chan, V. T. T., Sun, Z., Tang, S., Chen, L. J., Wong, A., Tham, C. C., Wong, T. Y., Chen, C., Ikram, M. K., Whitson, H. E., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.08.009 · Cited by 360
Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
Zuroff, L., Daley, D., Black, K. L., & Koronyo-Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275
Self-citationIdentification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Shi, H., Koronyo, Y., Rentsendorj, A., Regis, G. C., Sheyn, J., Fuchs, D.-T., Kramerov, A. A., Ljubimov, A. V., Dumitrascu, O. M., Rodriguez, A. R., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02134-w · Cited by 230
Self-citation
Metadata
- Authors
- Hart, N. J., Koronyo, Y., Black, K. L., & Koronyo-Hamaoui, M.
- Venue
- Acta Neuropathologica
- Published
- 2016-09-19
- Volume
- 132
- Issue
- 6
- Pages
- 767-787
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2521439892
- Cited by
- 261
- References
- 186
- FWCI
- 14.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.